Pages that link to "Q44589709"
Jump to navigation
Jump to search
The following pages link to A critical role for Stat3 signaling in immune tolerance (Q44589709):
Displaying 50 items.
- Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy (Q24798754) (← links)
- Signaling by STATs (Q24805570) (← links)
- Molecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in Mice (Q26765030) (← links)
- IFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases (Q26778206) (← links)
- Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages (Q26783748) (← links)
- Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions (Q27014714) (← links)
- Transcriptome Profiling Reveals Disruption of Innate Immunity in Chronic Heavy Ethanol Consuming Female Rhesus Macaques (Q27334505) (← links)
- Coordinated regulation of myeloid cells by tumours (Q28395157) (← links)
- Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells (Q28742177) (← links)
- STATs in cancer inflammation and immunity: a leading role for STAT3 (Q29547203) (← links)
- The STATs of cancer--new molecular targets come of age (Q29614601) (← links)
- Immunosuppressive strategies that are mediated by tumor cells (Q29636247) (← links)
- Melanoma NOS1 expression promotes dysfunctional IFN signaling (Q30413226) (← links)
- Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway (Q30427748) (← links)
- Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling (Q31126452) (← links)
- The induction of APC with a distinct tolerogenic phenotype via contact-dependent STAT3 activation (Q33498507) (← links)
- Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma (Q33761711) (← links)
- Signaling pathways induced by a tumor-derived vaccine in antigen presenting cells (Q33895525) (← links)
- Inhibition of STAT3 activity re-activates anti-tumor immunity but fails to restore the immunogenicity of tumor cells in a B-cell lymphoma model (Q34028436) (← links)
- A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs. (Q34146683) (← links)
- Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. (Q34248349) (← links)
- Suppressors of cytokine signaling and immunity (Q34279168) (← links)
- FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling (Q34459845) (← links)
- Murine myeloid dendritic cells that phagocytose apoptotic T cells inhibit the immune response via NO. (Q34482265) (← links)
- Progress towards the development of SH2 domain inhibitors (Q34581878) (← links)
- FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer (Q34755205) (← links)
- Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3 (Q34773094) (← links)
- S100B attenuates microglia activation in gliomas: Possible role of STAT3 pathway (Q34821218) (← links)
- Novel CD47: SIRPα dependent mechanism for the activation of STAT3 in antigen-presenting cell (Q35000908) (← links)
- STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo (Q35015488) (← links)
- HDAC inhibition and graft versus host disease (Q35016985) (← links)
- Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma (Q35064011) (← links)
- High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma (Q35186102) (← links)
- Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model. (Q35626914) (← links)
- Regulation of TLR signaling and inflammation by SOCS family proteins (Q35630518) (← links)
- Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer? (Q35681308) (← links)
- Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice (Q35799053) (← links)
- Mechanisms and functional significance of tumour-induced dendritic-cell defects (Q35968465) (← links)
- Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. (Q36048656) (← links)
- Role of STAT3 in lung cancer (Q36086059) (← links)
- Recent advances in dendritic cell biology (Q36094388) (← links)
- Immunology and Immunotherapy of Head and Neck Cancer (Q36100837) (← links)
- CTL-based cancer preventive/therapeutic vaccines for carcinomas: role of tumour-associated carbohydrate antigens (Q36121116) (← links)
- Antisense therapy for cancer (Q36133133) (← links)
- S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. (Q36177932) (← links)
- Role of immature myeloid cells in mechanisms of immune evasion in cancer (Q36208862) (← links)
- Signals from dying cells: tolerance induction by the dendritic cell (Q36232679) (← links)
- Technology insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies (Q36303951) (← links)
- Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer (Q36304018) (← links)
- Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions (Q36305646) (← links)